Zhaoke Ophthalmology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	35.36	69.32	18.75	-	-	-
Revenue Growth (YoY)	-38.20%	269.73%	-	-	-	-
Cost of Revenue	17.93	17.53	4.5	-	-	-
Gross Profit	17.42	51.8	14.25	-	-	-
Selling, General & Admin	128.56	134.28	136.29	116.06	178.82	36.54
Research & Development	226.96	203.7	333.05	296.43	220.06	81.78
Other Operating Expenses	12.94	12.94	-1.26	-0.15	-0.01	-1.37
Operating Expenses	368.45	350.92	468.09	412.34	398.87	116.96
Operating Income	-351.03	-299.12	-453.84	-412.34	-398.87	-116.96
Interest Expense	-9.03	-9.5	-7.92	-3.14	-1.95	-1.66
Interest & Investment Income	75.23	75.23	77.4	30.42	5.04	2.58
Currency Exchange Gain (Loss)	-4.71	-4.71	-3.65	-29.73	13.41	-5.49
Other Non Operating Income (Expenses)	15.71	-	-	-	-1,763	-669.98
EBT Excluding Unusual Items	-273.83	-238.11	-388.01	-414.8	-2,146	-791.49
Asset Writedown	-10.81	-10.81	-	-	-	-
Other Unusual Items	6.32	11.42	3.52	7.48	16.09	64.51
Pretax Income	-278.31	-237.49	-384.49	-407.32	-2,130	-726.98
Income Tax Expense	-	-	0.55	-	-	-
Net Income	-278.31	-237.49	-385.04	-407.32	-2,130	-726.98
Net Income to Common	-278.31	-237.49	-385.04	-407.32	-2,130	-726.98
Shares Outstanding (Basic)	546	546	544	542	412	151
Shares Outstanding (Diluted)	546	546	544	542	412	151
Shares Change (YoY)	0.20%	0.41%	0.32%	31.47%	173.12%	-5.63%
EPS (Basic)	-0.51	-0.43	-0.71	-0.75	-5.16	-4.81
EPS (Diluted)	-0.51	-0.43	-0.71	-0.75	-5.16	-4.81
Free Cash Flow	-253	-263.82	-360.13	-409.7	-310.67	-169.79
Free Cash Flow Per Share	-0.46	-0.48	-0.66	-0.76	-0.75	-1.12
Gross Margin	49.28%	74.72%	75.98%	-	-	-
Operating Margin	-992.78%	-431.49%	-2420.47%	-	-	-
Profit Margin	-787.13%	-342.58%	-2053.54%	-	-	-
Free Cash Flow Margin	-715.53%	-380.56%	-1920.70%	-	-	-
EBITDA	-314.86	-263.22	-420.16	-384.55	-377.53	-100.7
D&A For EBITDA	36.17	35.91	33.68	27.78	21.34	16.25
EBIT	-351.03	-299.12	-453.84	-412.34	-398.87	-116.96

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.